# The Medicines (Applications for Grant of Product Licences—Products for Human Use) Regulations 1993, Paragraph 22


Where the applicant, in relation to all or any particular therapeutic indications, omits any information by virtue of paragraph 5 of Schedule 2—
(a) detailed proposals for the programme of studies referred to in that paragraph (including a proposed period for carrying them out) for the purposes of a reassessment of the benefit/risk profile in relation to those indications; and
(b) a statement as to any proposal that the product in question should be administered for those indications only under strict medical supervision, possibly in a hospital, and, for a radiopharmaceutical to which Directive 89/343/EEC applies, by an authorized person.

---
Source: https://www.legislation.gov.uk/uksi/1993/2538/schedule/1/paragraph/22 (the official version)
Page: https://openlegislation.uk/medicines-applications-for-grant-of-product-licencesproducts-for-human-use-regulations-1993/schedule-1/paragraph-22
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.

